Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

DOR

Dor (DOR)

Dor Biopharma
Von:
Sortieren nach:
 Showing the most relevant articles for your search:AMEX:DOR
DatumZeitQuelleÜberschriftSymbolFirma
07/04/200615h19Business WireDOR BioPharma Announces Advances in Mucosal Vaccines for Botulinum Toxin; Antigens are Made Using Dowpharma's Pfenex ExpressionAMEX:DORDor Biopharma
06/04/200621h28Business WireDOR BioPharma Announces Private Equity Financing of $3.65 Million with Institutional InvestorsAMEX:DORDor Biopharma
30/03/200616h00Business WireDOR BioPharma Reports Year End 2005 Financial Results and Accomplishments; DOR Provides Guidance on Regulatory Filings on orBecAMEX:DORDor Biopharma
08/02/200615h25Business WireDOR BioPharma Provides Financial Guidance and Update on European Regulatory Plans for orBec(R)AMEX:DORDor Biopharma
30/01/200623h48Business WireDOR BioPharma Announces Positive Phase I Results of RiVax(TM), its Vaccine Against Ricin Toxin; Vaccine is Immunogenic and WellAMEX:DORDor Biopharma
25/01/200616h31Business WireDOR BioPharma Achieves Manufacturing Milestone in Development of RiVax(TM); DOR and Its Collaborators Achieve 2nd Milestone AheaAMEX:DORDor Biopharma
20/01/200614h10Business WireDOR BioPharma Reports Positive New Survival Findings from Previously Completed Phase II and III Clinical Trials of orBec(R); ResAMEX:DORDor Biopharma
19/01/200615h26Business WireDOR BioPharma Secures $6 Million Equity Commitment from Fusion CapitalAMEX:DORDor Biopharma
15/11/200515h04Business WireDOR BioPharma Plans FDA NDA and European MAA Filing Strategy for orBecAMEX:DORDor Biopharma
14/11/200522h26Business WireDOR BioPharma Inc. Reports Third Quarter 2005 Financial Results and Reviews Recent Achievements; Conference Call Scheduled for NAMEX:DORDor Biopharma
07/11/200513h00Business WireDOR BioPharma to Present at the Rodman & Renshaw Techvest 7th Annual Healthcare ConferenceAMEX:DORDor Biopharma
02/11/200512h00Business WireDOR BioPharma Executes Letter of Intent for Acquisition of Gastrotech Pharma; Acquisition Bolsters Biotherapeutics PipelineAMEX:DORDor Biopharma
01/11/200522h34Business WireDOR BioPharma Receives Notice of Delisting from American Stock Exchange; Company to Continue to Negotiate Potential Compliance-AAMEX:DORDor Biopharma
14/10/200515h17Business WireDOR BioPharma Provides Update on Programs and Corporate MattersAMEX:DORDor Biopharma
15/09/200523h41PR Newswire (US)Dr. Chris Dale, Vice President, Technology, Cambrex Biopharmaceuticals and Dr. Robert N. Brey, Chief Scientific Officer, DOR BioAMEX:DORDor Biopharma
26/07/200519h07PR Newswire (US)DOR BioPharma and Dowpharma Enter Into a Joint Development Agreement for BT-VACC(TM), DOR's Oral Vaccine Against Botulinum ToxinAMEX:DORDor Biopharma
15/06/200512h30Business WireDOR BioPharma, Inc. Announces Positive Interim Results from Phase I Clinical Trial of RiVax, Its Ricin Toxin VaccineAMEX:DORDor Biopharma
13/06/200517h14Business WireDOR BioPharma to Present at the Rodman & Renshaw Techvest 2nd Annual Security and Connectivity ConferenceAMEX:DORDor Biopharma
04/05/200516h51Business WireDOR BioPharma to Present at the Rodman & Renshaw Techvest 2nd Annual Global Healthcare ConferenceAMEX:DORDor Biopharma
04/05/200516h51Business WireDOR BioPharma to Present at the Rodman & Renshaw Techvest 2nd Annual Global Healthcare ConferenceAMEX:DORDor Biopharma
04/05/200514h30Business WireDOR BioPharma Appoints T. Jerome Madison to Board of DirectorsAMEX:DORDor Biopharma
04/05/200514h30Business WireDOR BioPharma Appoints T. Jerome Madison to Board of DirectorsAMEX:DORDor Biopharma
07/01/200514h30PR Newswire (US)DOR BioPharma and Cambrex Enter into a Development and Manufacturing Process Agreement for RiVax(TM)AMEX:DORDor Biopharma
 Showing the most relevant articles for your search:AMEX:DOR